Pharmacy Times

JANUARY 22, 2024

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

Vaccines 127

Vaccines Immunization 127

Pharmacy Times

DECEMBER 11, 2024

Assessing pre-treatment TIL levels in young breast cancer patients could help predict response to neoadjuvant chemotherapy.

Immunization 130

Immunization Chemotherapy 130

STAT

OCTOBER 14, 2024

Companies that are developing new medicines for autoimmune conditions, as well as other immune system disorders, have brought in more money and closed more deals so far this year than most other areas, including the cardiometabolic field, data from investment bank Oppenheimer show.

Immunization 144

Immunization 144

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. The transaction has been approved by both companies’ board of directors and is expected to close later in the second quarter of 2024.

Immunization 59

Immunization 59

The Checkup by Singlecare

NOVEMBER 26, 2024

Vitamin D Vitamin D coupons Most people think of vitamin D as the sunshine vitamin without realizing how big of an impact it has on our immune system. Low levels of vitamin D have been linked to poor immune function and fatigue, which can inhibit your recovery from COVID, says Simpson. Who should avoid vitamins for post-COVID fatigue?

Immunization 94

Immunization Hospitals FDA 94

Fierce Pharma

MAY 2, 2024

With Moderna’s COVID-19 sales on the backfoot following the switch to an endemic vaccine market, the Massachusetts-based biopharma is busy laying the groundwork for its next potential mRNA shot in | Moderna currently expects initial approvals of its RSV vaccine to start rolling in during the first half of 2024, the company said Thursday.

Vaccines 99

Vaccines Immunization 99

pharmaphorum

APRIL 10, 2024

billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA nephropathy (IgAN). It is the largest acquisition in the biopharma sector so far in 2024. In another departure from its focus on genetic medicines, Vertex Pharma has agreed a $4.9

Immunization 105

Immunization 105

European Pharmaceutical Review

MAY 14, 2024

Takeda and AC Immune SA have agreed a global option and license agreement for a potential first-in-class Abeta-targeting active immunotherapy for Alzheimer’s. AC Immune’s related immunotherapies targeting Abeta are part of the deal, including the Alzheimer’s treatment ACI-24.060.

Immunization 97

Immunization 97

Fierce Pharma

JULY 31, 2024

The whole respiratory syncytial virus (RSV) vaccine field took a beating when the Centers for Disease Control and Prevention’s (CDC's) immunization committee doled out a limited recommendation last | The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month.

Vaccines 81

Vaccines Immunization 81

Fierce Pharma

JANUARY 2, 2024

AstraZeneca and Sanofi have scored first in | AstraZeneca and Sanofi have scored first in China with an approval for their respiratory syncytial virus (RSV) immunization Beyfortus for infants, with the companies expecting the shot to be available there for the 2024-25 season.

Immunization 85

Immunization 85

The Thyroid Pharmacist

DECEMBER 29, 2023

I am hoping to feel more settled in 2024. I am wrapping up some projects in early 2024 and I am carving out more time for myself and my own healing. Adaptogens may also be anti-inflammatory, neuroprotective, and supportive of a healthy immune function. Does Adrenal Fatigue Exist? Gut Recovery Program (est.

Adverse Reactions 74

Adverse Reactions Immunization Dosage 74

Digital Pharmacist

DECEMBER 20, 2023

A few types of free screenings you could offer: Wellness exams Full cholesterol panels Blood pressure and glucose screenings Health screenings also offer a jumping-off point for promoting other healthcare services, such as senior immunizations for conditions like shingles and pneumonia, or flu shots.

Communication 98

Communication Immunization 98

European Pharmaceutical Review

JANUARY 11, 2024

Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb).

Immunization 115

Immunization 115

PQA

NOVEMBER 14, 2024

November 7-8, 2024, for the 2024 PQA Leadership Summit. PQA also announced five students who completed the 2024 PQA Healthcare Quality IQ (HQIQ), sponsored by PQA by Innovaccer. PQA members gathered in Arlington, Va., The summit focused on PQA's recent and ongoing work to develop standard pharmacy quality measures.

Specialty Pharmacies 52

Specialty Pharmacies Documentation Patient Care Immunization 52

European Pharmaceutical Review

JANUARY 2, 2024

The transaction is expected to close in the first quarter of 2024, subject to certain closing conditions. Data showed that 18 percent of industry professionals believed this to be the case, with personalised medicine predicted as the top trend in 2024, according to 16 percent of the respondents.

Immunization 98

Immunization 98

The Checkup by Singlecare

JANUARY 11, 2024

10 potential upcoming FDA approvals for 2024 Pharmacists are on the frontline when it comes to getting patients the right medications for their treatment plan. Therefore, you’ll want to prepare and adapt to potential 2024 FDA approvals, which may include the following drugs currently in the pipeline. g/dL versus 0.50

FDA 52

FDA Immunization Patient Care Packaging 52

PQA

SEPTEMBER 12, 2023

The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement and test high priority immunization pharmacy measure concepts. PQA has issued a request for interest (RFI) to gauge interest and willingness to participate in these pilots.

Immunization 40

Immunization Patient Care 40

BioPharm

MAY 10, 2024

Regeneron’s work in CAR-T cell therapy development includes engineering receptor architecture to improve CAR-T cell sensitivity and improve immune response.

Immunization 52

Immunization 52

European Pharmaceutical Review

JUNE 25, 2024

This indicates that the treatment can help to preserve important immune functions in the body. This one-year data for OCREVUS SC was presented in April this year at the 2024 American Academy of Neurology (AAN) Annual Meeting. percent, over 48 weeks of treatment.

Immunization 111

Immunization 111

pharmaphorum

SEPTEMBER 27, 2022

The principal is much the same as in checkpoint inhibitor treatment: preventing the cancer cells from evading detection by the body’s immune system and highlighting them for destruction by T cells. The ability for cancer cells to create this suppressive tumour microenvironment (TME) allows them to avoid detection by the immune system.

Vaccines 97

Vaccines Immunization 97

European Pharmaceutical Review

AUGUST 9, 2023

The pharmaceutical company announced that it plans to submit to global health authorities in 2024. There were 470 participants in the REMIX-1 study. In REMIX-2, the clinical trial enrolled 455 participants with CSU.

Immunization 94

Immunization Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

OCTOBER 25, 2024

the biologic has the potential to deliver anti-tumour responses in the majority of patients with ES-SCLC” The ongoing Phase I trial is assessing the antibody-drug conjugate both as a single treatment and as a combination therapy together with the immune checkpoint inhibitor atezolizumab.

Chemotherapy 97

Chemotherapy Compounding Immunization 97

European Pharmaceutical Review

APRIL 10, 2024

It also suggests the potential to use NX-5948 as a therapeutic option for immune indications with CNS involvement such as multiple sclerosis.” These data were presented at the 2024 American Association for Cancer Research (AACR) 2024 Annual Meeting.

Immunization 97

Immunization 97

PQA

DECEMBER 13, 2024

As wenearthe end of 2024,itsagreattimeto reflect on our accomplishments.We I want to share highlights from five major areas of work in 2024. Our August 2024 report, Advancing Medication Therapy Management Quality Measurement, describes critical actions necessary to advance the quality of MTM services.

Communication 52

Communication Patient Care Immunization 52

European Pharmaceutical Review

SEPTEMBER 21, 2023

IL-13 has a role in the immune and inflammatory processes underlying atopic dermatitis signs and symptoms. The new administration method will be available in the UK for tralokinumab patients from early 2024. The monoclonal antibody biologic treatment has been developed to bind to and inhibit the interleukin (IL)-13 cytokine.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Immunization 105

pharmaphorum

AUGUST 31, 2022

In May, a Phase 2 study started, comparing Kaiku’s electronic patient-reported outcome (ePRO) approach to evaluating immune-related adverse events to the standard model of care in cancer patients treated with checkpoint inhibitor drugs, with results due towards the end of 2023 or in early 2024.

Chemotherapy 116

Chemotherapy Immunization Hospitals 116

STAT

APRIL 11, 2024

Medicare actuaries expect the drug, which is called Leqembi and sold by Eisai in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024. That is projected to increase to $3.5 billion in 2025 for the entire Medicare program, a spokesperson for the Centers for Medicare and Medicaid Services confirmed.

Chemotherapy 103

Chemotherapy Immunization 103

Hospital Pharmacy Europe

FEBRUARY 23, 2023

The complement system is a component of the immune system that is central to the detection and destruction of invading pathogens and consists of three pathways. According to the press release, syfovre is currently under review by the European Medicines Agency with a decision expected in early 2024.

FDA 98

FDA Immunization Hospitals 98

PQA

OCTOBER 4, 2024

As part of this work, PQA has launched a proof-of-concept pilot using several PQA pharmacy measure concepts to evaluate the effectiveness of pharmacies in improving adult immunization rates through value-based arrangements (VBA) with payers. Submissions for breakout session proposals are due Tuesday, November 12, 2024. Register here!

Immunization 52

Immunization Specialty Pharmacies 52

European Pharmaceutical Review

MAY 29, 2024

Biomica’s microbiome -based immuno-oncology candidate and the anti-PD1 immune checkpoint inhibitor is being evaluated in eleven participants. These d ata will be presented at the 2024 American Society of Clinical Oncology (ASCO) annual meeting.

Immunization 98

Immunization 98

European Pharmaceutical Review

OCTOBER 2, 2024

The planned transaction is expected to be completed in Q4 of 2024, subject to customary closing conditions. Article: Tackling immune-mediated disease with CAR Tregs Biotech firm Regor Pharmaceuticals (USA) is developing medicines to address large unmet needs in fields ranging from oncology, metabolism to auto-immunity.

Immunization 64

Immunization 64

European Pharmaceutical Review

SEPTEMBER 5, 2024

2 These are cells commonly found in the stroma of the tumour, which play an important role in inhibiting the body’s own immune response to the tumour, mediated through CD8+ T-cells (tumour-infiltrating lymphocytes). An investigator-led Phase II trial is ongoing, comparing setanaxib with placebo, with results due in Q4 2024.

Immunization 59

Immunization 59

pharmaphorum

AUGUST 25, 2022

The double-headed antibody binds to CD3 on T cells and redirects them to BCMA-expressing myeloma cells, with the aim of stimulating an immune attack on the tumour, which remains incurable despite a slew of new therapies reaching the market in recent years.

FDA 98

FDA Immunization 98

The Thyroid Pharmacist

NOVEMBER 29, 2023

At this time, shipping is not available outside of the US, and I know many of you have been asking about this, so I will add it to my list of projects to research in 2024. We have 95 expiring in March 2024.) We have 106 expiring in April 2024.) We have 35 expiring in May 2024, and 139 expiring in August 2024.)

Health and Personal Care Stores 74

Health and Personal Care Stores Immunization Labelling Compounding 74

European Pharmaceutical Review

JUNE 20, 2024

Investigating the potential of small molecule drugs Fruquintinib and other immunoncology therapies However, results are not clear cut as there is still need for more research into the exact mechanism and interaction of small molecule drugs and the immune system. 2024; 25(4), 371–382. References Stucchi E, Bartolini M, Airoldi M, et al.

Immunization 98

Immunization Compounding Hospitals 98

The Checkup by Singlecare

JANUARY 30, 2024

Mast cells are part of the immune system that are present in the skin. Skin and the nervous system are intimately connected as early as week three of gestation, Dr. Hooper says. Recent research shows that when you’re stressed, the brain releases chemicals and triggers mast cells. This can cause a stress rash or hives.

Immunization 105

Immunization Compounding 105

Pharmaceutical Technology

APRIL 28, 2023

THN391 binds the inflammation-driving component of fibrin, known for activating the immune responses in neurodegenerative and ophthalmologic diseases. We look forward to advancing our first candidate, THN391, into clinical trials, and expect to announce key safety and proof of mechanism clinical data by the end of 2024.”

Immunization 52

Immunization 52